BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below. Some articles will have been accepted based in part or entirely on reviews undertaken for other BMJ Group journals. These will be reproduced where possible.
The review will be guided by an expert panel, but there is no mention of the membership of this panel. The choice of members, recruitment strategies and methods for supporting the expression and understanding of ideas from different perspectives is an ethical issue.
There are plans for presenting the findings for feedback and discussion to a group of young people with experience of teenage pregnancy. I am not quite sure whether this actually means young women, as an inclusion criterion is young women. I would like the research team to consider involving young people earlier in the process. They might be asked directly, instead of asking the expert panel alone to identify interventions which they may have experienced and giving feedback. One advantage of involvement at this stage is to sensitise the review team to issues important to young people. There is also the possibility of presenting the initial review question and the body of mapped evidence to them too. They may have ideas that can usefully contribute to a discussion for refining the focus of the review. Figure 1 displays the design clearly for this work and helps readers navigate the study. It includes the early consultation with review users, but not the later involvement for discussing the findings. Phase three of this work lists six different syntheses. When I first read this figure, I wanted to advise the authors to maximise learning by investigating the potential overlaps, synergies and contradictions, I hope the review team are able to construct a framework that will accommodate all these syntheses. However, by the time I read to page 15, I realised they had this in mind "To aid this process we will develop a methodological and conceptual matrix or logic model to integrate our findings". It would be helpful to include this task in the figure, allowing for its likely iterative development.
Search strategy: the review team may wish to search PROSPERO in case this reveals a team currently working in a similar area, thereby allowing exchange of study references relevant to both reviews. Some reviews have benefited from the use of social media (e.g. Twitter) to find the most recent studies.
The "outcomes" section surprised me because it appears to be the outcomes of studies, not the outcomes of interventions. Might it be helpful to use another term (e.g. findings of interest) to distinguish these concepts from the outcomes that are more usually listed at this stage in a systematic review of effects of intervention? Study exclusion criteria: the review team will only attempt to translate major studies (e.g. randomised controlled trials) that are found in languages other than English. There are strong methodological reasons for including RCTs published in languages other than English. I suspect the reasons are not so strong for including other types of studies such as process evaluations or qualitative studies; if such studies are excluded, evidence may be missing but may not bias the final result of a synthesis as happens in a statistical meta-analysis. Rather than calling RCTs "major" studies, the argument for translating these, but not other studies, may be expressed more accurately and more neutrally.
I cannot comment on the applicability of MMAT tool for appraising studies in this area as it is described in a journal that is not open access. I understand that the CerQual (certainty of the quality of evidence) tool is developing fast, and may no longer be using the term "certainty". This should be checked before publication of the protocol.
PROGRESS: I believe the last concept in this mnemonic is "social capital" rather than "social status".
The term "clinical heterogeneity" seems a little incongruous when related to pregnancy, a nine month experience, very little of which is spent in a clinical setting. How about heterogeneity across studies judged by apparent differences or statistical tests? How many studies are adequate for sub-group analysis?
Page 4, line 49. I think there are problems here with matching numbers in the text with references listed at the end of the paper.
More up-to-date than reference 10 are the chapters in Gough D, Oliver S, Thomas J. (2012) Introduction to systematic reviews.
London: Sage.
VERSION 1 -AUTHOR RESPONSE
>>This protocol is for an impressive piece of work that will employ several parallel syntheses with their methods chosen to match the sub-questions and type of completed studies. Overall, the focus of study and choice of methods are well argued, and the methods well described. I have noted a few issues for the review team to consider before undertaking their work.
Thank you >>The review will be guided by an expert panel, but there is no mention of the membership of this panel. The choice of members, recruitment strategies and methods for supporting the expression and understanding of ideas from different perspectives is an ethical issue.
We have added further detail of the membership of the expert group to the text.
>>There are plans for presenting the findings for feedback and discussion to a group of young people with experience of teenage pregnancy. I am not quite sure whether this actually means young women, as an inclusion criterion is young women.
We will be engaging with a group of teenage mums who are in contact with the Flying start programme. We have clarified this detail in the protocol.
>>I would like the research team to consider involving young people earlier in the process. They might be asked directly, instead of asking the expert panel alone to identify interventions which they may have experienced and giving feedback. One advantage of involvement at this stage is to sensitise the review team to issues important to young people. There is also the possibility of presenting the initial review question and the body of mapped evidence to them too. They may have ideas that can usefully contribute to a discussion for refining the focus of the review.
Thank you for this suggestion. We took considerable advice from our expert panel, members of which are in day to day contact with relevant young people who considered that the best time to engage with young people was when we had findings to discuss. We have adopted their consensus opinion. >>Figure 1 displays the design clearly for this work and helps readers navigate the study. It includes the early consultation with review users, but not the later involvement for discussing the findings. Phase three of this work lists six different syntheses. When I first read this figure, I wanted to advise the authors to maximise learning by investigating the potential overlaps, synergies and contradictions, I hope the review team are able to construct a framework that will accommodate all these syntheses. However, by the time I read to page 15, I realised they had this in mind "To aid this process we will develop a methodological and conceptual matrix or logic model to integrate our findings". It would be helpful to include this task in the figure, allowing for its likely iterative development.
"Development of methodological and conceptual matrix or logic model to integrate findings" has been added to the diagram. >>Search strategy: the review team may wish to search PROSPERO in case this reveals a team currently working in a similar area, thereby allowing exchange of study references relevant to both reviews. Some reviews have benefited from the use of social media (e.g. Twitter) to find the most recent studies.
Thank you for this helpful suggestion, we will pursue this line of action but have not modified the protocol as this would fit within our last round of searches when we check for recently published literature by various means (described in the section "supplementary searches").
>>The "outcomes" section surprised me because it appears to be the outcomes of studies, not the outcomes of interventions. Might it be helpful to use another term (e.g. findings of interest) to distinguish these concepts from the outcomes that are more usually listed at this stage in a systematic review of effects of intervention?
Thank you, we have added "and other phenomena of interest" to the relevant headers. >>Study exclusion criteria: the review team will only attempt to translate major studies (e.g. randomised controlled trials) that are found in languages other than English. There are strong methodological reasons for including RCTs published in languages other than English. I suspect the reasons are not so strong for including other types of studies such as process evaluations or qualitative studies; if such studies are excluded, evidence may be missing but may not bias the final result of a synthesis as happens in a statistical meta-analysis. Rather than calling RCTs "major" studies, the argument for translating these, but not other studies, may be expressed more accurately and more neutrally.
Thank you we have modified the protocol accordingly.
>>I cannot comment on the applicability of MMAT tool for appraising studies in this area as it is described in a journal that is not open access. I understand that the CerQual (certainty of the quality of evidence) tool is developing fast, and may no longer be using the term "certainty". This should be checked before publication of the protocol.
We found the MMAT tool appealing chiefly because of it being a single tool to appraise multiple study designs (as opposed to choosing several different tools). Quality appraisal tools are not easy to apply consistently across several reviewers; the MMAT comes with a tutorial and seems relatively straightforward to apply. So we are aiming for consistency between study types and between reviewers. The tool has been developed at McGill University. We have been in contact with one of the authors, who is keen to receive feedback on our use of the tool and will give support if we need it.
>>PROGRESS: I believe the last concept in this mnemonic is "social capital" rather than "social status".
Corrected, thank you >>The term "clinical heterogeneity" seems a little incongruous when related to pregnancy, a nine month experience, very little of which is spent in a clinical setting. How about heterogeneity across studies judged by apparent differences or statistical tests? How many studies are adequate for sub-group analysis?
We thank the reviewer for this perspicacious comment. We have clarified the use of the term clinical heterogeneity in the text. We add here (but not in the protocol paper as we wish to keep this close to the protocol document agreed with our funder) some of the thinking behind our approach:
Although the term clinical heterogeneity seems a little inconsistent when related to pregnancy, this review intends to detect it (clinical heterogeneity) from the descriptions of the trials populations. The term "clinical heterogeneity" may be replaced by "individual subject heterogeneity". By doing so, this review intends to keep distinct factors that describe the individual subject (clinical heterogeneity) from factors that can be regarded as study design or methodological issues. When appropriate, this review may contrast individual subject (clinical) and statistical heterogeneity with methodological heterogeneity, which includes issues related to study design, study conduct and publication bias.
With regards to statistical heterogeneity, this review intends to check if the variation between studies in the true treatment effects either in magnitude or direction is greater than the variation between individual subjects. If there is significant heterogeneity we would try to describe the variation between the studies and investigate possible sources of heterogeneity. If we can explain the heterogeneity, we may be able to produce a final estimate of the effect which adjusts for it. If not, we would carry-out meta-analysis which allows for heterogeneity, called random affects analyses.
This review intends to perform subgroup analysis on the type of interventions. For example, our searches to date have established four types of interventions. These we have initially categorised as: home visiting intervention, mobile phone intervention, emergency contraception intervention and community support agencies intervention. However, it is very unlikely that an investigation of heterogeneity will produce useful findings in the emergency contraception intervention case we have only found one has one study. To resolve this problem, this review intends to perform sensitivity analysis to establish the adequate number of studies needed for sub-group analysis. >>Page 4, line 49. I think there are problems here with matching numbers in the text with references listed at the end of the paper.
Thank you, corrected and checked all references >>More up-to-date than reference 10 are the chapters in Gough D, Oliver S, Thomas J. (2012) Introduction to systematic reviews. London: Sage.
Thank you, we agree a much better reference.
